DXCM Technical Analysis



As of date:5/24/2024
DXCM stock price:127.37
DXCM 50 DMA:132.79
DXCM 200 DMA:115.18
DXCM MACD (200-50):-17.61
DXCM RSI:44.91
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)44.91
Extremely
Oversold

Also see:
DXCM Market Cap History
DXCM Shares Outstanding History
DXCM YTD Return

Quotes delayed 20 minutes

Email EnvelopeFree DXCM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Notable Two Hundred Day Moving Average Cross - MDXG
48 minutes ago


FIBK Crosses Below Key Moving Average Level
48 minutes ago


South Plains Financial Breaks Below 200-Day Moving Average - Notable for SPFI
49 minutes ago


Bullish Two Hundred Day Moving Average Cross - BHRB
1 hour, 2 minutes ago


CoStar Group Breaks Below 200-Day Moving Average - Notable for CSGP
1 hour, 3 minutes ago


ConnectOne Bancorp (CNOB) Shares Cross Below 200 DMA
1 hour, 7 minutes ago


VALU Makes Bullish Cross Above Critical Moving Average
1 hour, 7 minutes ago


MAA Crosses Below Key Moving Average Level
1 hour, 11 minutes ago


Direxion Daily 20+ Year Treasury Bear 3X Shares (TMV) Shares Cross Above 200 DMA
1 hour, 11 minutes ago


Notable Two Hundred Day Moving Average Cross - BIV
1 hour, 11 minutes ago


Notable Two Hundred Day Moving Average Cross - SPAB
1 hour, 12 minutes ago


Baytex Energy Breaks Above 200-Day Moving Average - Bullish for BTE.CA
1 hour, 12 minutes ago


iShares Core 10+ Year USD Bond Breaks Below 200-Day Moving Average - Notable for ILTB
1 hour, 12 minutes ago


CP.CA Crosses Below Key Moving Average Level
1 hour, 12 minutes ago


IYR Makes Notable Cross Below Critical Moving Average
1 hour, 12 minutes ago


More Technical Analysis News

DXCM Technical AnalysisDXCM RSI
DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Co.'s products include: DecCom G6®, which is designed to allow Co.'s transmitter to run an algorithm to generate a glucose value; Dexcom G7®, which is designed for all people with diabetes ages two years and older, giving access to a diabetes management solution; DexCom Share®, which is a remote monitoring system, provided for use with any existing Dexcom system; Dexcom Real-Time API, which expands connectivity and interoperability of the Dexcom CGM digital ecosystem; and Dexcom ONE®.

When researching a stock like DexCom, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from DXCM Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for DXCM stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
DXCM DMADXCM MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
DexCom (DXCM) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

EW Technical Analysis
GEHC Technical Analysis
GILD Technical Analysis
HCA Technical Analysis
HOLX Technical Analysis
HSIC Technical Analysis
IDXX Technical Analysis
ILMN Technical Analysis
INCY Technical Analysis
IQV Technical Analysis
More Healthcare companies »

 

DXCM Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.